Drug
Cholestyramine Resin clinical trials
Also written Cholestyramine and Questran.
- studies test it
- 22
- open now
- 2
- in phase 3
- 6
- first study started
- 2007
Keep track of what changes. Save the Cholestyramine Resin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
20 studies that test it; most in 2010 (3)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2010 | 3 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 4
- Phase 3
- 6
- Phase 4
- 4
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 12
Sanofi (6) · Albireo (2) · National Heart, Lung, and Blood Institute (NHLBI) (2) · Louisville Metabolic and Atherosclerosis Research Center (2) · Ain Shams University (1) · Eli Lilly and Company (1) · Seoul National University Hospital (1) · Yonsei University (1)
Often tested with
Tested in the same studies.
Omega-3 fatty acid (4) · Alirocumab (3) · Atorvastatin (3) · Ezetimibe (3) · Niacin (3) · Fenofibrate (3) · Teriflunomide (3) · Rosuvastatin (2)
Studies
Open first, then newest update. How each study uses Cholestyramine Resin is read from its arms, and is right about nine times in ten.
Testing it · 22
- PFAS Clinical TrialNot yet recruitingPhase 2Emory UniversityNCT07836023Written as Cholestyramine
- Exploratory Evaluation of the Effect of Cholestyramine on Serum Levels of POPs in Obese Female PatientsRecruitingNot applicableCentre Hospitalier Universitaire de NiceNCT05966727Written as Cholestyramine Powder
- Efficacy and Safety of Cholestyramine in the Management of Hyperphosphatemia in Adult Hemodialysis PatientsCompletedPhase 4Ain Shams UniversityNCT05577507Written as Cholestyramine Resin 4000 MG [Questran]
- Double-blind, Randomised Study of A3384 in BAM/BADCompletedPhase 2AlbireoNCT02078856Written as A3384
- A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384CompletedPhase 1AlbireoNCT02963077Written as CRC (A3384)
- A Study to Evaluate the Effect of Cholestyramine on LOXO-783 in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT05894928Written as Cholestyramine
- An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial HypercholesterolemiaCompletedPhase 3SanofiNCT03510884Written as Cholestyramine
- Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel SyndromeTerminatedPhase 2Pharmascience Inc.NCT04046328Written as Enteric-Coated Cholestyramine (ECC) Capsule
- A Clinical Study to Assess the Effect of Change of Bile Acid on the PD and Safety of Metformin and Microbiome ProfilesCompletedPhase 1Seoul National University HospitalNCT04335526Written as Cholestyramine Resin
- An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial HypercholesterolemiaCompletedPhase 3SanofiNCT03510715Written as Cholestyramine
- An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial HypercholesterolemiaCompletedPhase 2SanofiNCT02890992Written as cholestyramine
- Effect of Lipid Modifying Drugs on HDL Function in Patients With HyperlipidemiaCompletedNot applicableYonsei UniversityNCT02942602Written as Cholestyramine 8 g
- PRELIMINARY EVALUATION OF PHARMACOLOGICAL LOWERING OF AGEsCompletedPhase 4University of ChileNCT02249897Written as CHOLESTYRAMINE
- Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt HyperthyroidismStatus unknownPhase 3Clinical Research Centre, MalaysiaNCT03303053Written as Cholestyramine Powder 4g
- Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)CompletedPhase 3National Heart, Lung, and Blood Institute (NHLBI)NCT00000488Written as cholestyramine
- Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple SclerosisCompletedPhase 3SanofiNCT01863888Written as cholestyramine
- A Study to Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese VolunteersCompletedPhase 1SanofiNCT02046629Written as cholestyramine
- NHLBI Type II Coronary Intervention StudyCompletedPhase 3National Heart, Lung, and Blood Institute (NHLBI)NCT00000594Written as cholestyramine
- Pharmacokinetic and Tolerability Study of 14 mg Single Dose of Teriflunomide in Subjects With Severe Renal ImpairmentCompletedPhase 1SanofiNCT01239459Written as Cholestyramine
- A Single Research Site Bile Acid Sequestrant Acceptability (BASA) Scale Pilot Validation StudyCompletedPhase 4Louisville Metabolic and Atherosclerosis Research CenterNCT01062269Written as Cholestyramine
See all 22 studies that test Cholestyramine Resin →
Given in every arm · 4 — Cholestyramine Resin is usual care beside what is tested
- Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic CancerRecruitingPhase 1City of Hope Medical CenterNCT06454383Written as Cholestyramine
- Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic MalignanciesRecruitingPhase 1City of Hope Medical CenterNCT05443425Written as Cholestyramine
- Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple SclerosisActive, not recruitingPhase 3SanofiNCT06141473Written as Cholestyramine
- Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American PatientsActive, not recruitingPhase 2City of Hope Medical CenterNCT05014646Written as Cholestyramine
Codes
What other systems call Cholestyramine Resin · ClinicalTrials.gg INT007212
- MeSH (NLM) D002792Cholestyramine ResinOne source ClinicalTrials.gov
- UNII (FDA) 4B33BGI082CHOLESTYRAMINEOne source FDA
- RxNorm 2447One source FDA
- NCI Thesaurus C28929CholestyramineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D002792 | Cholestyramine Resin | One source ClinicalTrials.gov |
| UNII (FDA) | 4B33BGI082 | CHOLESTYRAMINE | One source FDA |
| RxNorm | 2447 | — | One source FDA |
| NCI Thesaurus | C28929 | Cholestyramine | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.